Safety of Intravitreal Injection of Stivant, a Biosimilar to Bevacizumab, in Rabbit Eyes

PURPOSE: To evaluate the safety of intravitreal injection of Stivant, a biosimilar to bevacizumab, in rabbits using electrophysiological and histological analysis. METHODS: Both eyes of 41 New Zealand albino rabbits were injected with 0.1 mL (2.5 mg) of Stivant. The rabbits were scheduled to be sacr...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Ophthalmic Vis Res
Glavni autori: Lashay, Alireza, Faghihi, Hooshang, Mirshahi, Ahmad, Khojasteh, Hassan, Khodabande, Alireza, Riazi-Esfahani, Hamid, Amoli, Fahimeh Asadi, Pour, Elias Khalili, Delrish, Elham
Format: Artigo
Jezik:Inglês
Izdano: PUBLISHED BY KNOWLEDGE E 2020
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7431730/
https://ncbi.nlm.nih.gov/pubmed/32864065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18502/jovr.v15i3.7453
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items